What a Statistically Significant Result Means in a Dog Supplement Study

A statistically significant result in a dog supplement study means the measured difference cleared a preset math screen for chance, usually p < 0.05. It does not grade how much a dog improved, whether owners would notice the change, or whether the formula may help support healthy function in normal daily life.

A 12-year-old spayed Beagle mix came to me because her owner was torn between two senior-support chews, both advertising significant results. At home she would climb the back deck, pause twice on those 14 steps, then lie flat for an hour before dinner. Her pattern fit what I see often in aging dogs, Spleen Qi deficiency with weak hind-quarter drive, low stamina, soft stool after long days. I told the owner to ignore the starburst on the front and read the methods table first, because only one study named its primary outcome before testing.

My call screens for chance first, size of help second

I keep every longevity tool organized around that one Spleen Qi pattern, food therapy for steady digestion, Tui-na and acupuncture for hind-quarter tone, plus Western herbs or nutrients that may help support stamina and joint comfort. Statistical significance only earns a product a second look. My recommendation stays evidence-bounded: do not change routine on p < 0.05 alone. I want a prespecified primary outcome, an effect size with a confidence interval, baseline and final values, number of dogs enrolled and finished, and duration that matches real use.

What would change my mind is straightforward, a preregistered randomized trial in client-owned dogs, adequate power, published full results with adverse events, then an independent replication showing a similar owner-noticeable effect. Most marketing does not meet that bar. The current evidence does not because small laboratory cohorts, short feeding periods, and post hoc endpoints can pass the math screen while leaving daily function unchanged.

What the math is actually testing

Physiology comes before statistics. A supplement that may help support cartilage metabolism, mitochondrial efficiency, or gut absorption still has to move a marker the body can feel, gait speed, rise time, play duration, stool consistency. Researchers set a null position, often no difference between supplement and placebo, then ask how surprising the observed data would be if that null were true. A p-value of 0.03 means data that extreme would occur about 3 times in 100 by chance alone under the model. It is not the chance the product works.

Confidence intervals carry more practical weight. If a mobility score improves 2 points on a 60-point scale with a 95% interval from 0.2 to 3.8, the result may be statistically significant yet too small for most owners to detect. If the interval runs from 6 to 14 points, the signal deserves attention. The NASC quality program reminds owners that manufacturing consistency matters as much as study math, because an untested jar may not match the tested batch. General supplement literacy from the NIH Office of Dietary Supplements makes the same point for people, read identity, amount, and directions before trusting an outcome claim.

Myth against reality in label language

Myth says significant equals important and non-significant equals useless. Reality is narrower. A large kennel trial can find a tiny, clinically trivial change significant because sample size sharpens detection. A small pilot can miss a useful change because power is low. Multiple outcomes without adjustment inflate false positives, which is why I check whether the headline endpoint was primary or one of many explored after the fact.

A hiking-home Border Collie, 6 years old and conditioned for trail work, showed me the tradeoff. His owner chased a powder with a significant biomarker shift and skipped the basics. After six weeks the blood value looked better on paper, yet on our usual 0.4-mile warm-up loop he still lagged on the last rise and needed two rest stops. We had optimized a number without supporting the pattern. We returned to measured feeding, weight control, and conditioning, using supplements only as adjuncts that may help support recovery and normal joint function. For label reading, the red-flag fillers guide helps separate formula quality from headline claims, and the joint supplement buying guide shows what a complete methods section should disclose.

Where my usual rule has to bend

Housed on slick hardwood, a 34-kg senior mixed-breed with low stamina and rear-end weakness taught me when to bend without breaking the rule. His owner tracked morning rises with a phone timer. Over three weeks the average time to stand from a down stayed flat, and the formal score in a small published trial she brought in was not significant. Strictly by p-value I would have stopped the trial formula. Yet her logs showed he had regained the evening short hallway walk without panting, and his weight had steadied at 34.1 kg after a prior 1.3-kg slide linked to poor appetite.

In that setting I continued the supplement for one defined block while holding food, exercise, and body condition steady, because the whole-patient pattern was stabilizing even though the study endpoint was not. The National Center for Complementary and Integrative Health frames this well, look for study design, size, controls, and replication rather than a single p-value. Low prior probability and flexible analysis can produce striking but fragile findings, a caution detailed in PLOS Medicine. A bend is a timed n-of-1 with exit criteria, not open-ended use.

The sequence I run before the next jar

I run the same sequence whether the claim involves NAD+ precursors, antioxidants, or senior-support blends. First, find the primary outcome and ask if it mirrors home life, rise time, walk tolerance, play bouts. Second, read effect size and interval, not only the p-value. Third, check dogs, dose form, duration, dropout rate, and whether results were intention-to-treat. Fourth, scan adverse events and concomitant diet and drugs. Fifth, confirm the lot is identity-tested and the label lists amounts per chew, not a hidden blend.

If those answers line up with the Spleen Qi pattern in front of me, a short, measured trial that may help support stamina or mobility is reasonable, with a written stop date and one observable target. If the paper hides numbers behind significant without data, I pass.